Finland· FI-REL-REL30576
Dretine
A drospirenone and ethinylestradiol product containing drospirenone + ethinylestradiol, registered in Finland by Theramex Ireland Limited. The same ATC class is registered in 13 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Drospirenone and ethinylestradiol is registered in 13 of 19 countries.
Countries holding a registration under ATC G03AA12 (drospirenone and ethinylestradiol), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 8 of them publish a price we can compare per daily dose
Drospirenone and ethinylestradiol · ATC G03AA12
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
The record
At a glance
Fimea (Finland)- Active substance
- Drospirenone + Ethinylestradiol
- Manufacturer
- Theramex Ireland Limited
- Country
- Finland (FI)
- ATC code
- G03AA12
- ATC class
- Drospirenone and ethinylestradiol
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
517 interactions on record for drospirenone and ethinylestradiol.
Graded by severity as the source publishes them — 50 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Drospirenone and ethinylestradiol · interactions on record
517 records
- 50 severe
- 386 moderate
- 49 minor
Most severe, free to view
- Tranexamic acidB02AA02severe
- HeminB06AB01severe
- BosentanC02KX01severe
- GriseofulvinD01AA08severe
32 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Drospirenone and ethinylestradiol in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaABELLAARDEZ Pharma, spol. s r.o., Kosoř
- SpainAIDRA 3 MG/0,03 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGLaboratorios Cinfa S.A.
- PolandAsubtelaDelfarma Sp. z o.o.
- NetherlandsBaradly 0,03 mg/3 mg filmomhulde tablettenHemony Pharmaceutical Germany GmbH
- FranceBELANETTE 0,02 mg/3 mg, comprimé pelliculéBAYER HEALTHCARE
- United KingdomAcondro 0.03mg/3mg tabletsViatris UK Healthcare Ltd
- GermanyAidaBayer Vital Gmbh
- SwitzerlandEloine, FilmtablettenBerlis AG
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Aliane, Danselle 21
- Belgium · Annaïs 20, Annaïs 30 Ceres Pharma
- Bulgaria · Жанги, Крипинео
- Cyprus · Yasmin, Yasminelle
- Czechia · Abella, Cris
- Germany · Aida, Drospifem 20
- Denmark · Asubtela, Etindros 21
- Estonia · Jangee, Madeleine
- Spain · Aidra, Aidraelle
- France · Drospibel, Drospirenone/Ethinylestradiol
- United Kingdom (Northern Ireland) · Dretine, Ellanite
- Greece · Estrofix, Yasmin
- Croatia · Crypineo, Rosanne
- Hungary · Altforalle, Aranka
- Ireland · Dretine, Dretinelle
- Iceland · Asubtela, Yasmin
- Italy · Calindir, Cris
- Lithuania · Edrocont, Etindros
- Luxembourg · Annaïs 20 Ceres Pharma, Annaïs 30 Ceres Pharma
- Latvia · Etindros, Midiana
- Malta · Edrocont, Freedonel
- Netherlands · Baradly, Belanette
- Norway · Calima, Diza
- Poland · Asubtela, Axia
- Portugal · Aranka, Arankelle
- Romania · Yasmin
- Sweden · Diza, Maitalon
- Slovenia · Crypineo, Daylla
- Slovakia · Daylla, Emie
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ed619dcd-88ce-448d-88fd-1111fa150fb6 GET /v1/drugs/ed619dcd-88ce-448d-88fd-1111fa150fb6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "0.75",
"form": "tabletti, kalvopäällysteinen",
"route": "Suun kautta",
"ddd_unit": "ED",
"strength": "0.03 mg / 3 mg",
"atc_label": "drospirenoni ja etinyyliestradioli",
"ma_number": "24736",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL30576",
"authorised_at": "2010-09-10"
}See everything about drospirenone and ethinylestradiol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.